Seoul, South Korea

Choi Kyung Seok


Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Profile: Choi Kyung Seok

Introduction

Choi Kyung Seok is a prominent inventor based in Seoul, South Korea, recognized for his contributions to the field of pharmaceuticals. With a focus on innovative solutions, he has made strides in medical technology, particularly in the development of critical compounds used in medical imaging.

Latest Patents

Choi Kyung Seok holds a patent for a "Gadobutrol intermediate and gadobutrol production method using same." This patent discloses an intermediate capable of high-purity synthesis of gadobutrol, an essential MRI contrast agent. The innovative production method outlined in this patent utilizes this intermediate, represented by Chemical Formula 2 in the specification.

Career Highlights

Currently, Choi is associated with Enzychem Lifesciences Corporation, a company noted for its research and development in the life sciences sector. His dedication to enhancing medical imaging technology has positioned him as a key contributor in his field. With a patent to his name, he exemplifies the integration of research and practical application in the medical industry.

Collaborations

Throughout his career, Choi has collaborated with talented colleagues, including Jae Young Lee and Jong Soo Lee, fostering an environment of innovation and teamwork. Their combined expertise has significantly advanced the projects they undertake, driving forward the mission of Enzychem Lifesciences Corporation.

Conclusion

Choi Kyung Seok stands out as a notable inventor in the pharmaceutical landscape, with his work contributing to advancements in medical technology. His innovative patent for gadobutrol and its production reflects a commitment to enhancing patient care through improved medical imaging solutions. As he continues his work with his team, he is expected to make further impactful contributions to the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…